Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/4632
Title: | Value based pricing for NHS drugs: An opportunity not to be missed? |
Authors: | Claxton, K Briggs, AH Buxton, MJ Culyer, AJ McCabe, C Walker, S Sculpher, MJ |
Issue Date: | 2008 |
Publisher: | British Medical Journal |
Citation: | BMJ 336(7638): 251-254, Feb 2008 |
Abstract: | The policy debate about price, value, and innovation in pharmaceuticals is at a critical stage for the NHS. Karl Claxton and colleagues describe the key principles of value based pricing and consider some of the concerns about such a scheme |
Description: | The official puclished version of the article can be found at the link below |
URI: | http://www.bmj.com/content/336/7638/251 http://bura.brunel.ac.uk/handle/2438/4632 |
DOI: | http://dx.doi.org/10.1136/bmj.39434.500185.25 |
ISSN: | 0959-8138 |
Appears in Collections: | Health Economics Research Group (HERG) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Fulltext.pdf | 427.65 kB | Adobe PDF | View/Open |
Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.